Medolone (Aciclovir)

Aciclovir is a nucleoside analogue that is selectively phosphorylated by viral thymidine kinase. The resulting triphosphate form inhibits viral DNA polymerase, causing premature termination of viral DNA synthesis and thereby halting viral replication.

The dosage of Medolone is determined by the prescribing clinician based on the specific infection, patient weight, renal function, and severity of disease. Only a qualified healthcare professional should set the dosing regimen.

Aciclovir’s pregnancy category is not definitively established. It should be used during pregnancy only when the potential benefit outweighs any possible risk to the fetus. Breastfeeding mothers should consult their physician, as the drug can be excreted in breast milk.

To order Medolone, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and required import documentation.

Medolone (intravenous aciclovir) offers rapid, high‑level plasma concentrations suitable for severe or systemic herpes infections, whereas oral agents such as valacyclovir or famciclovir are used for milder cases. IV aciclovir is preferred for neonatal infections, encephalitis, and immunocompromised patients requiring immediate antiviral activity.

Medolone should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use and discard any solution that appears discolored or contains particles.

Medolone is given by intravenous infusion. The recommended infusion time varies with the dose and patient condition, but it is typically administered over 30–60 minutes. Administration should be performed by qualified healthcare personnel in a clinical setting.

The most serious adverse events include nephrotoxicity, especially in patients with pre‑existing kidney impairment; neurotoxicity such as confusion, seizures, or hallucinations; and severe hypersensitivity reactions like anaphylaxis. Prompt monitoring of renal function and neurological status is essential during therapy.

Medolone is contraindicated in patients with known hypersensitivity to aciclovir or any component of the formulation. It should be used with caution, or avoided, in individuals with severe renal impairment, pregnant women unless clearly indicated, and those receiving other nephrotoxic medications without close monitoring.